Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention.

ABSTRACT:

Objectives

The purpose of this study was to evaluate ischemic and bleeding outcomes of unselected cancer patients undergoing percutaneous coronary intervention (PCI).

Background

The number of cancer patients undergoing PCI is increasing despite concerns regarding ischemic and bleeding risks.

Methods

Between 2009 and 2017, consecutive patients undergoing PCI were prospectively included in the Bern PCI Registry. Cancer-specific data including type, date of initial diagnosis, and health status at index PCI were collected. We performed propensity score matching to adjust for baseline differences between patients with and without cancer. The primary ischemic endpoint was the device-oriented composite endpoint (cardiac death, target vessel myocardial infarction, target lesi

SUBMITTER: Ueki Y 

PROVIDER: S-EPMC8352169 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature